The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Singularity Equity Fund I

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+11.1%1-day move

₹384.00

prior close

₹366.05

base price

In-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+7.6+6.6+6.0+7.3+11.1+11.7+8.1+7.0+7.6+3.5-1.0-0.0+2.4—

Up moveDown movePending

AI summary

Singularity Equity Fund I, a non-promoter investor, acquired 6,49,600 equity shares of Hemant Surgical Industries Ltd through preferential allotment on May 15, 2026. This was pursuant to the conversion of Convertible Warrants into equity shares. Prior to the acquisition, Singularity held 2,49,600 shares (1.91%). After conversion, its holding increased to 8,99,200 shares representing 6.90% of total diluted capital. The company's equity share capital increased from Rs.13.03 crore to Rs.14.54 crore as a result of this allotment. Singularity is not part of the promoter group.

Likely market impact

Singularity Equity Fund I nearly quadrupled its stake from ~1.9% to ~6.9%, indicating strong institutional interest in the company. The transaction was via warrant conversion, not open market purchase, so it is non-dilutive in the traditional sense but increases the total share count.